Clinical Trial Update: Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for varlitinib in combination with capecitabine in biliary tract cancer (Phase 2/Phase 3) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Varlitinib (varlitinib)

Snippet

Sponsor: ASLAN Pharmaceuticals | Conditions: Biliary Tract Cancer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-08-03